STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	11 Months Ended	12 Months Ended								107 Months Ended
	Dec. 31, 2003	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007	Dec. 31, 2006	Dec. 31, 2005	Dec. 31, 2004	Dec. 31, 2011
Cumulative effect of change in accounting principle				$ (220,835)
Change in derivative liability				587,609		6,656,676
Shares issued for:
Conversion of convertible notes			1,380,091						248,370
Exercise of options			109,641	63,604
Acquisition of Opexa									23,750,000
Shares repurchased and cancelled	(325)
Stock-based compensation expense		489,914	508,550	650,249	1,901,570	1,876,103	2,749,617	2,487,741	123,333
Warrant Expense					603,850	845,275	1,568,966	2,373,888
Transition of warrants from equity instruments to liability instruments								(10,658,496)
Net loss	(126,003)	(5,968,448)	(5,469,067)	(1,433,922)	(11,852,152)	(14,667,367)	(12,649,170)	(14,856,724)	(31,411,736)	(100,680,787)
Ending Balances	(68,968)	7,195,364	3,968,713	7,375,148	1,487,397	2,133,585	7,422,898	(5,580,034)	(3,228,942)	7,195,364
Cash
Shares issued for:
Shares issued	1,000	8,618,157		4,689,165	8,651,579		21,153,519	5,346,217	9,000
Beneficial Conversion Feature
Discount related to:
Discount	28,180							831,944	855,849
Warrants Attached To Debt
Discount related to:
Discount	28,180			37,453				1,433,108	1,848,502
Services
Shares issued for:
Shares issued		87,028	64,350		48,965			1,012,400	849,000
Licensing Agreements
Shares issued for:
Shares issued								1,868,384	427,075
Reverse merger with Sportan
Shares issued for:
Shares issued									(147,733)
Convertible Debt
Shares issued for:
Shares issued								7,649,446	288,366
Debt
Shares issued for:
Shares issued							180,000	161,000
Convertible Notes Payable
Discount related to:
Discount				439,493
Warrants
Shares issued for:
Shares issued				1,074,935
Common Stock
Par value adjustment				(6,329,888)
Shares issued for:
Conversion of convertible notes (in shares)			2,760,181						60,750
Conversion of convertible notes			27,602						30,375
Exercise of options (in shares)			141,520	60,400
Exercise of options			1,416	26,280
Acquisition of Opexa (in shares)									250,000
Acquisition of Opexa									125,000
Shares cancelled (in shares)									(8,000)
Shares cancelled									(4,000)
Shares repurchased and cancelled (in shares)	(170,625)
Shares repurchased and cancelled	(85,313)
Ending Balances (in shares)	354,375	23,048,488	18,466,924	15,476,222	12,245,858	6,696,784	6,696,784	2,061,955	1,005,984	23,048,488
Ending Balances	177,187	230,485	184,670	154,762	6,122,888	3,348,351	3,348,351	1,030,977	502,992	230,485
Common Stock | Cash
Shares issued for:
Shares issued (in shares)	525,000	4,531,259		2,550,000	5,503,874		4,600,000	389,451	2,250
Shares issued	262,500	45,312		25,500	2,751,937		2,300,000	194,725	1,125
Common Stock | Services
Shares issued for:
Shares issued (in shares)		50,305	55,000		45,200			24,000	206,500
Shares issued		503	550		22,600			12,000	103,250
Common Stock | Licensing Agreements
Shares issued for:
Shares issued (in shares)								29,194	24,269
Shares issued								14,597	12,135
Common Stock | Reverse merger with Sportan
Shares issued for:
Shares issued (in shares)									99,740
Shares issued									49,870
Common Stock | Convertible Debt
Shares issued for:
Shares issued (in shares)								611,026	16,100
Shares issued								305,513	8,050
Common Stock | Debt
Shares issued for:
Shares issued (in shares)							34,829	2,300
Shares issued							17,374	1,150
Common Stock | Warrants
Shares issued for:
Shares issued (in shares)			34,001	619,964
Shares issued			340	309,982
Additional Paid in Capital
Cumulative effect of change in accounting principle				(1,976,457)
Par value adjustment				6,329,888
Change in derivative liability				587,609		10,658,496
Shares issued for:
Conversion of convertible notes			1,352,489						217,995
Exercise of options			108,225	37,324
Acquisition of Opexa									23,625,000
Shares cancelled									4,000
Shares repurchased and cancelled	84,988
Stock-based compensation expense		489,914	508,550	650,249	1,901,570	1,876,103	2,749,617	2,487,741	123,333
Warrant Expense					603,850	845,275	1,568,966	2,373,888
Transition of warrants from equity instruments to liability instruments								(10,658,496)
Ending Balances	(120,152)	107,645,666	98,496,382	96,463,658	84,929,481	76,498,054	63,118,180	39,783,452	27,805,805	107,645,666
Additional Paid in Capital | Cash
Shares issued for:
Shares issued	(261,500)	8,572,845		4,663,665	5,899,642		18,853,519	5,151,492	7,875
Additional Paid in Capital | Beneficial Conversion Feature
Discount related to:
Discount	28,180							831,944	855,849
Additional Paid in Capital | Warrants Attached To Debt
Discount related to:
Discount	28,180			37,453				1,433,108	1,848,502
Additional Paid in Capital | Services
Shares issued for:
Shares issued		86,525	63,800		26,365			1,000,400	745,750
Additional Paid in Capital | Licensing Agreements
Shares issued for:
Shares issued								1,853,787	414,940
Additional Paid in Capital | Reverse merger with Sportan
Shares issued for:
Shares issued									(197,603)
Additional Paid in Capital | Convertible Debt
Shares issued for:
Shares issued								7,343,933	280,316
Additional Paid in Capital | Debt
Shares issued for:
Shares issued							162,626	159,850
Additional Paid in Capital | Convertible Notes Payable
Discount related to:
Discount				439,493
Additional Paid in Capital | Warrants
Shares issued for:
Shares issued			(340)	764,953
Accumulated Deficit
Cumulative effect of change in accounting principle				1,755,622
Change in derivative liability						(4,001,820)
Shares issued for:
Net loss	(126,003)	(5,968,448)	(5,469,067)	(1,433,922)	(11,852,152)	(14,667,367)	(12,649,170)	(14,856,724)	(31,411,736)
Ending Balances	$ (126,003)	$ (100,680,787)	$ (94,712,339)	$ (89,243,272)	$ (89,564,972)	$ (77,712,820)	$ (59,043,633)	$ (46,394,463)	$ (31,537,739)	$ (100,680,787)